pCMV-Cyclin D1 Citations (10)
Originally described in: Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y Proc Natl Acad Sci U S A. 1998 Feb 17. 95(4):1392-7. PubMed Journal
Articles Citing pCMV-Cyclin D1
| Articles |
|---|
| SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. Mittal MK, Singh K, Misra S, Chaudhuri G. J Biol Chem. 2011 Jan 7;286(1):469-79. doi: 10.1074/jbc.M110.164384. Epub 2010 Nov 2. PubMed |
| p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors. Dok R, Kalev P, Van Limbergen EJ, Asbagh LA, Vazquez I, Hauben E, Sablina A, Nuyts S. Cancer Res. 2014 Mar 15;74(6):1739-51. doi: 10.1158/0008-5472.CAN-13-2479. Epub 2014 Jan 28. PubMed |
| Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells. Jia Y, Domenico J, Swasey C, Wang M, Gelfand EW, Lucas JJ. PLoS One. 2014 May 21;9(5):e97448. doi: 10.1371/journal.pone.0097448. eCollection 2014. PubMed |
| Epigenetically altered miR-193b targets cyclin D1 in prostate cancer. Kaukoniemi KM, Rauhala HE, Scaravilli M, Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL, Visakorpi T. Cancer Med. 2015 Sep;4(9):1417-25. doi: 10.1002/cam4.486. Epub 2015 Jul 1. PubMed |
| MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1. Jiang J, Huang J, Wang XR, Quan YH. Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2278-84. PubMed |
| CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability. Dozier C, Mazzolini L, Cenac C, Froment C, Burlet-Schiltz O, Besson A, Manenti S. Oncogene. 2017 Jun 29;36(26):3781-3788. doi: 10.1038/onc.2016.506. Epub 2017 Feb 13. PubMed |
| Alternative Polyadenylation of PRELID1 Regulates Mitochondrial ROS Signaling and Cancer Outcomes. Gillen AE, Brechbuhl HM, Yamamoto TM, Kline E, Pillai MM, Hesselberth JR, Kabos P. Mol Cancer Res. 2017 Dec;15(12):1741-1751. doi: 10.1158/1541-7786.MCR-17-0010. Epub 2017 Sep 14. PubMed |
| MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN. Roth SA, Hald OH, Fuchs S, Lokke C, Mikkola I, Flaegstad T, Schulte J, Einvik C. Oncotarget. 2018 Apr 6;9(26):18160-18179. doi: 10.18632/oncotarget.24793. eCollection 2018 Apr 6. PubMed |
| CDK4 inhibition diminishes p53 activation by MDM2 antagonists. Sriraman A, Dickmanns A, Najafova Z, Johnsen SA, Dobbelstein M. Cell Death Dis. 2018 Sep 11;9(9):918. doi: 10.1038/s41419-018-0968-0. PubMed |
| miR-193b represses influenza A virus infection by inhibiting Wnt/beta-catenin signalling. Yang X, Zhao C, Bamunuarachchi G, Wang Y, Liang Y, Huang C, Zhu Z, Xu D, Lin K, Senavirathna LK, Xu L, Liu L. Cell Microbiol. 2019 May;21(5):e13001. doi: 10.1111/cmi.13001. Epub 2019 Jan 25. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.